Ironwood Pharmaceuticals | IRWD - 股本和储备



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 666.8M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Astellas Pharma JPY 1.94T 113.64B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Coherus Biosciences USD 60.84M 17.78M 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Moderna USD 6.76B 647M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Pacira USD 671.98M 18.08M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Takeda JPY 7.56T 215.7B 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12